Franck Rahaghi

1.2k total citations
48 papers, 481 citations indexed

About

Franck Rahaghi is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Franck Rahaghi has authored 48 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 8 papers in Physiology. Recurrent topics in Franck Rahaghi's work include Pulmonary Hypertension Research and Treatments (24 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Protease and Inhibitor Mechanisms (7 papers). Franck Rahaghi is often cited by papers focused on Pulmonary Hypertension Research and Treatments (24 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Protease and Inhibitor Mechanisms (7 papers). Franck Rahaghi collaborates with scholars based in United States, Germany and Canada. Franck Rahaghi's co-authors include Robert C. Basner, Marc Miravitlles, Robert P. Baughman, Mary Beth Scholand, James K. Stoller, Charlie Strange, Robert A. Sandhaus, James Stocks, Steven D. Nathan and Michael J. Krowka and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

Franck Rahaghi

45 papers receiving 470 citations

Peers

Countries citing papers authored by Franck Rahaghi

Since Specialization

Citations

This map shows the geographic impact of Franck Rahaghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Rahaghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Rahaghi more than expected).

Fields of papers citing papers by Franck Rahaghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Rahaghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Rahaghi. The network helps show where Franck Rahaghi may publish in the future.

Co-authorship network of co-authors of Franck Rahaghi

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Rahaghi. A scholar is included among the top collaborators of Franck Rahaghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Rahaghi. Franck Rahaghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Caring for Rural Patients With Interstitial Lung Disease 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rebecca Bascom, (unknown), Mary Beth Scholand, (unknown), Anoop M. Nambiar, Sonye K. Danoff, Franck Rahaghi, Tejaswini Kulkarni, (unknown)	0
2	Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients 2025 ·The Lancet Respiratory Medicine ·Franck Rahaghi, Marc Humbert, Marius M. Hoeper, R. James White, Robert P. Frantz, Paul M. Hassoun, Anna R. Hemnes, Steven M. Kawut, Vallerie V. McLaughlin, Gergely Mészáros, Peter G. M. Mol, Steven D. Nathan, (unknown), Farbod N. Rahaghi, Olivier Sitbon, Norman Stockbridge, Jason Weatherald, Faı̈ez Zannad, Sandeep Sahay	1
3	Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies 2024 ·BMC Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), Syed A. A. Rizvi, (unknown), (unknown), (unknown), (unknown), (unknown), Miguel Sierra‐Hoffman, (unknown), Franck Rahaghi	1
4	Exploring Chemotherapeutic Agents as Countermeasures against Respiratory Viruses: Antiviral Potential of Sugar Alcohols 2023 ·Medical Research Archives ·(unknown), Jonna B. Westover, (unknown), Franck Rahaghi	2
5	Effects of COVID-19 pandemic on the management of pulmonary hypertension 2022 ·Respiratory Medicine ·(unknown), Sandeep Sahay, Oksana A. Shlobin, Francisco Rafael Martins Soto, Stephen C. Mathai, (unknown), Christopher J. Mullin, Deborah J. Levine, (unknown), Kristin B. Highland, Eduardo Bossone, Abby Poms, (unknown), Vijay Balasubramanian, (unknown), Franck Rahaghi, Jean Elwing	3
6	Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease 2022 ·CHEST Journal ·Franck Rahaghi, Nicholas A. Kolaitis, Ayodeji Adegunsoye, João A. de Andrade, Kevin R. Flaherty, Lisa Lancaster, Joyce Lee, Deborah J. Levine, Ioana R. Preston, Zeenat Safdar, Rajan Saggar, Sandeep Sahay, Mary Beth Scholand, Oksana A. Shlobin, David A. Zisman, Steven D. Nathan	45
7	Riociguat for Sarcoidosis-Associated Pulmonary Hypertension 2021 ·CHEST Journal ·Robert P. Baughman, Oksana A. Shlobin, Rohit Gupta, Peter J. Engel, Jeffrey Stewart, Elyse E. Lower, Franck Rahaghi, (unknown), Steven D. Nathan	26
8	Clinical phenotyping: role in treatment decisions in sarcoidosis 2020 ·European Respiratory Review ·Robert P. Baughman, Mary Beth Scholand, Franck Rahaghi	25
9	Improving Screening for Alpha-1 Antitrypsin Deficiency with Direct Testing in the Pulmonary Function Testing Laboratory 2020 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·(unknown), (unknown), (unknown), (unknown), Franck Rahaghi	5
10	Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study 2020 ·BMC Pulmonary Medicine ·Franck Rahaghi, Zeenat Safdar, Anne Brown, João A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, María L. Padilla, Imre Noth, Mary Beth Scholand, Adrian Shifren, Steven D. Nathan	6
11	Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study 2020 ·European Respiratory Review ·Franck Rahaghi, Nadera Sweiss, Lesley Ann Saketkoo, Mary Beth Scholand, Joseph B. Barney, Alicia K. Gerke, Elyse E. Lower, Mehdi Mirsaeidi, (unknown), Mark J. Rumbak, Lobelia Samavati, Robert P. Baughman	10
12	Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD 2019 ·Journal of Critical Care ·Franck Rahaghi, Laurel Omert, Virginia Clark, Robert A. Sandhaus	1
13	Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence 2017 ·Respiratory Research ·Franck Rahaghi, Marc Miravitlles	23
14	Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension 2017 ·Respiratory Medicine ·Nicholas S. Hill, Franck Rahaghi, Namita Sood, Reiner Frey, Hossein Ardeschir Ghofrani	11
15	Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease 2017 ·Lung ·(unknown), (unknown), Felix Hernandez, (unknown), Kristin B. Highland, Franck Rahaghi, J.P. Mehta	8
16	Imatinib in Pulmonary Arterial Hypertension: C‐Kit Inhibition 2014 ·Pulmonary Circulation ·Samar Farha, Raed A. Dweik, Franck Rahaghi, Raymond L. Benza, Paul M. Hassoun, Robert P. Frantz, Fernando Torres, Deborah A. Quinn, (unknown), Serpil C. Erzurum, Kewal Asosingh	30
17	Shared Medical Appointments in Pulmonary Hypertension 2014 ·Pulmonary Circulation ·Franck Rahaghi, (unknown), (unknown), Gustavo Ferrer, (unknown), J.P. Mehta, Luís Vicente Franco de Oliveira, (unknown)	9
18	The Prevalence of Alpha-1 Antitrypsin Deficiency Among Patients Found to Have Airflow Obstruction 2012 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Franck Rahaghi, Robert A. Sandhaus, Charlie Strange, D. Kyle Hogarth, Edward Eden, James Stocks, Michael J. Krowka, James K. Stoller	50
19	Physicians’ Views on Targeted Alpha-1 Antitrypsin Testing by Respiratory Therapists in PFT Labs and Their Awareness of Protections Offered by the Genetic Information Nondiscrimination Act (GINA) 2010 ·CHEST Journal ·(unknown), (unknown), (unknown), Gustavo Ferrer, (unknown), Luís Vicente Franco de Oliveira, (unknown), Franck Rahaghi	1
20	Physician Alert Suggesting Alpha-1 Antitrypsin Deficiency Testing in Pulmonary Function Test (PFT) Results 2009 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Franck Rahaghi, (unknown), (unknown), Luís Vicente Franco de Oliveira, (unknown), (unknown), James K. Stoller	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact